>23% effective is actually quite a good benefit, Well, my comment was pointing more to the disparity between the PR around the vaccine vs. the reality of it.

>23% effective is actually quite a good benefit, Well, my comment was pointing more to the disparity between the PR around the vaccine vs. the reality of it. It's well-known that it's a hit-or-miss proposition each year and, here, we're seeing evidence of further holes borne of the annual effort itself. That is, there's now a downside to actually following the advice, beyond side effects and ineffective vaccines. So, I'm speaking more to the juxtaposition of that reality against the "vaccine-is-everywhere-better-get-it-or-you-might-die" kind of PR in which public health officials and pharma engage every year.